Each year, SynBioBeta hosts the The Global Synthetic Biology Conference to showcase the latest cutting-edge developments in biology that are changing how we solve global problems. Antheia was a proud sponsor of this year’s event, and participated in two high impact talks designed to share our progress toward transforming pharmaceutical supply chains.
In this first video, CEO and co-founder of Antheia, Dr. Christina Smolke, speaks on the main stage at SynBioBeta on the importance that synthetic biology will play in transforming pharmaceutical supply chains and ending drug shortages.
Antheia at SynBioBeta: Building Resilient Pharmaceutical Supply Chains for Accessible Medicines
In the industry panel below, Dr. Smolke is joined by John Nicols (Organicols), Cameron Fox (Luminary Labs), and Kevin Costa (Absci) for a discussion on the challenges of our current pharmaceutical supply chains and how synthetic biology is enabling innovative solutions that are ready to scale now.
For more information on Antheia’s activities at SynBioBeta, please click here.